Aortic Aneurysm Market Report 2026

The aortic aneurysm market size has grown rapidly in recent years. It will grow from $4.06 billion in 2025 to $4.47 billion in 2026 at a compound annual growth rate (CAGR) of 10%. The growth in the historic period can be attributed to aging population demographics, increased prevalence of cardiovascular diseases, improvements in diagnostic imaging technologies, expansion of vascular surgery capabilities, wider adoption of surgical repair techniques.

The aortic aneurysm market size is expected to see rapid growth in the next few years. It will grow to $6.62 billion in 2030 at a compound annual growth rate (CAGR) of 10.3%. The growth in the forecast period can be attributed to increasing demand for minimally invasive cardiovascular treatments, rising investments in advanced vascular devices, expansion of screening programs for aneurysm detection, growing integration of ai-based diagnostic tools, increasing focus on long-term patient outcome optimization. Major trends in the forecast period include increasing adoption of minimally invasive evar procedures, rising use of advanced imaging for early detection, growing preference for personalized surgical planning, expansion of endovascular device innovation, enhanced focus on post-procedure patient monitoring.

The increasing consumption of alcohol and tobacco is expected to drive the growth of the aortic aneurysm market in the coming years. Alcohol and tobacco consumption refers to the use of alcoholic beverages and tobacco products, which are substances known to have significant effects on cardiovascular health. The rising prevalence of alcohol and tobacco use is primarily fueled by greater social acceptance and easy accessibility, as these substances remain widely available despite their well-documented health risks. Increased alcohol and tobacco consumption heightens the demand for aortic aneurysm treatments because long-term exposure to these substances weakens arterial walls and accelerates vascular degeneration, leading to a higher incidence of aneurysm formation that requires medical intervention. For example, in November 2024, according to the Office for Health Improvement & Disparities, a UK-based government organization, between April 2023 and March 2024, a total of 310,863 adults aged 18 and above accessed drug and alcohol treatment services, representing a 7% increase from 290,635 adults in the previous year. Thus, the growing consumption of alcohol and tobacco is contributing to the expansion of the aortic aneurysm market.

Major companies operating in the aortic aneurysm market are concentrating on developing and launching innovative solutions such as the Stent-Graft System. A stent-graft system is a medical device used to manage vascular conditions, particularly aneurysms or tears in blood vessels. It integrates a stent, which offers structural support, with a graft made of synthetic material that lines the blood vessel. For example, in August 2024, Terumo India, an India-based medical technology company, introduced the TREO Abdominal Stent-graft system. TREO is an advanced device designed to treat abdominal aortic aneurysms, combining a durable stent with a biocompatible graft to provide effective support and reduce the risk of rupture. This system aims to improve patient outcomes by enabling minimally invasive procedures and enhancing long-term stability in vascular interventions. Consequently, increasing alcohol and tobacco consumption is contributing to the growth of the aortic aneurysm market.

In May 2023, Striker Corporation, a US-based medical technologies company, acquired Cerus Endovascular Ltd. for an undisclosed amount. Through this acquisition, Striker Corporation aims to enhance its existing aneurysm treatment solutions worldwide. Cerus Endovascular Ltd. is a UK-based medical device company specializing in aneurysm treatment solutions.

Major companies operating in the aortic aneurysm market are Cardiatis SA, Cook Medical Inc., Endologix LLC, W L Gore & Associates Inc., JOTEC GmbH, Lombard Medical Limited, Medtronic plc, Terumo Corporation, MicroPort Scientific Corporation, Boston Scientific Corporation, Endospan Ltd., LifeTech Scientific Corporation, B. Braun Melsungen AG, EndoEvolution LLC, CryoLife Inc., Intuitive Surgical Inc., Synovis Micro Companies Alliance Inc., Meril Life Sciences Pvt. Ltd., Vitalitec International GmbH, Getinge AB, CONMED Corporation, TriVascular Technologies Inc., Vascutek Ltd., Aptus Endosystems Inc., Bolton Medical Inc., EndoVascular Technologies Inc., Endurant Energy LLC, LeMaitre Vascular Inc.

North America was the largest region in the aortic aneurysm market in 2025. The regions covered in the aortic aneurysm market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the aortic aneurysm market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs are impacting the aortic aneurysm market by increasing costs of imported stent grafts, catheters, surgical instruments, imaging equipment, and specialized biomaterials used in aneurysm repair procedures. Hospitals and surgical centers in North America and Europe are most affected due to dependence on imported endovascular devices, while Asia-Pacific faces higher costs in device manufacturing and procurement. These tariffs are contributing to higher procedural costs and delayed technology adoption. However, they are also encouraging domestic production of vascular devices, regional supplier development, and increased investments in local medical device manufacturing.

The aortic aneurysm market research report is one of a series of new reports that provides aortic aneurysm market statistics, including aortic aneurysm industry global market size, regional shares, competitors with a aortic aneurysm market share, detailed aortic aneurysm market segments, market trends and opportunities, and any further data you may need to thrive in the aortic aneurysm industry. This aortic aneurysm market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

An aortic aneurysm is a balloon-like enlargement in the aorta, the main artery that carries blood from the heart through the chest and torso. Various medical conditions, genetic disorders, and high blood pressure can weaken the aorta, and the blood flow along these weakened walls can lead to an aneurysm. These aneurysms may be tubular or spherical in shape.

The main types of aortic aneurysms include thoracic aortic aneurysm (TAA) and abdominal aortic aneurysm (AAA). Thoracic aortic aneurysm (TAA) occurs due to a weakened area in the aorta located in the chest. The available treatments include open surgical repair (OSR) and endovascular aneurysm repair (EVAR), which are performed in hospitals, clinics, ambulatory surgery centers (ASCs), and other medical facilities.

The aortic aneurysm market includes revenues earned by entities by open surgery and endovascular repair. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.